Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins Genomics, Igenbio Collaborate on Genome Analysis Services

NEW YORK (GenomeWeb) – Eurofins Genomics and genome analysis firm Igenbio today announced a deal to combine their expertise in sequencing and analysis services for microbial, fungal, and algal organisms.

The agreement will provide researchers a one-stop shop for their genomics projects with analysis of raw extracted DNA, the partners said. Financial and other terms of the deal were not disclosed.

"With the increased integration we are now able to provide complete genome analysis [and] transcriptomics data integration, along with [a] gene manipulation tool set and synthetic biology platform for our customers," Igenbio President and CEO Vinayak Kapatral said in a statement. Igenbio is based in Chicago and provides microbial bioinformatics and gene manipulation tools and services.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.